# Grupo Supervielle S.A. (SUPV)

> Financial Services · AR · Reports in ARS

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SUPV/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | ARS 1,116.20B | ARS -4.22B | ARS 81.19B | ARS 1,007.65B | ARS 1,190.00B |
| 2025 | ARS 1,373.04B | ARS 1.79B | ARS -787.89B | ARS 1,049.42B | ARS 1,006.88B |
| 2024 | ARS 2,310.68B | ARS 119.83B | ARS 1,342.63B | ARS 91.25B | ARS 797.74B |
| 2023 | ARS 2,547.88B | ARS 87.48B | ARS 1,576.59B | ARS 8.27B | ARS 743.40B |
| 2022 | ARS 466.13B | ARS -7.60B | ARS 539.30B | ARS 6.63B | ARS 287.32B |
| 2021 | ARS 177.55B | ARS -2.10B | ARS 87.74B | ARS 4.71B | ARS 100.34B |
| 2020 | ARS 110.33B | ARS 4.27B | ARS -16.94B | ARS 9.89B | ARS 53.81B |
| 2019 | ARS 83.22B | ARS -3.32B | ARS 90.24B | ARS 12.90B | ARS 31.88B |
| 2018 | ARS 37.26B | ARS 2.57B | ARS 11.85B | ARS 16.45B | ARS 26.08B |
| 2017 | ARS 20.49B | ARS 2.20B | ARS -29.31B | ARS 13.69B | ARS 20.07B |
| 2016 | ARS 14.10B | ARS 1.31B | ARS -788.60M | ARS 7.40B | ARS 11.72B |
| 2015 | ARS 8.98B | ARS 674.17M | ARS 2.45B | ARS 1.91B | ARS 2.37B |
| 2014 | ARS 4.98B | ARS 364.33M | ARS 1.71B | ARS 1.10B | ARS 1.71B |
| 2013 | ARS 1.51B | ARS 236.76M | ARS 757.53M | ARS 1.31B | ARS 1.35B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.85 |
| Liabilities / Eq | 6.39 |
| Current Ratio | 1.91 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 49.91 |
| Gross Debt / FCF | 3.48 |

## Other views

- [Metrics](https://sponda.capital/en/SUPV.md)
- [Charts](https://sponda.capital/en/SUPV/charts.md)
- [Compare](https://sponda.capital/en/SUPV/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.
